Redd&Whyte Appoints New UK Sales Manager
News Feb 21, 2013
Redd&Whyte today announced that it is strengthening its UK presence with the appointment of Sarah Chaudhry as its new UK sales manager. Sarah comes with specialist knowledge of life science laboratory equipment, making her well placed to support Redd&Whyte’s high quality range of Preddator low-volume microplate dispensers throughout the UK.
Sarah has over 12 years’ experience in sales management within major life science equipment companies including Elga Process Water and Sartorius where she supported a range of laboratory systems. Sarah’s commercial expertise is underpinned by a degree in Biomedical Sciences from Sheffield Hallam University. This provides Sarah with extensive knowledge of life science research and automated laboratory equipment to draw from, which she will use to offer advice and support on Redd&Whyte’s Preddator low-volume dispensers range.
Sarah Chaudhry, Redd&Whyte’s UK Sales Manager commented: “I am very pleased to be working for such an innovative UK company and the four channel Preddator system is a very exciting new development. I am looking forward to meeting scientists and showing them how Preddator’s unique dispense head design will help them to accurately and continuously dispense low-volumes and to explaining how it will benefit them by generating consistent assay results, while making substantial savings on reagents and operating costs.”
Roger Poole, Managing Director of Redd&Whyte continued: “We want to develop our UK presence with the Preddator so are delighted to facilitate this by adding a new UK sales manager to our team. Sarah’s specialist approach to supporting laboratory equipment, we believe will allow us to enhance our reputation for delivering unrivalled low-volume dispensing performance to all our existing and potential UK clients.”
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral DrugsNews
In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.READ MORE